Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.
2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
4.

Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.

Hanna GJ, D'Aquila RT.

Clin Infect Dis. 2001 Mar 1;32(5):774-82. Epub 2001 Feb 28. Review.

5.

Resistance testing debate: does it make the grade?

Simmons P.

Res Initiat Treat Action. 1999 Oct;5(4):9-12.

PMID:
11366943
6.

HIV resistance testing: methods, utility, and limitations.

Alcorn TM, Faruki H.

Mol Diagn. 2000 Sep;5(3):159-68. Review.

PMID:
11070150
7.

Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs.

Dunne AL, Mitchell FM, Coberly SK, Hellmann NS, Hoy J, Mijch A, Petropoulos CJ, Mills J, Crowe SM.

AIDS. 2001 Aug 17;15(12):1471-5.

PMID:
11504978
8.
9.

Genotypic resistance tests in the management of the HIV-infected patient at virological failure.

Aceti A, Carosi G.

Scand J Infect Dis Suppl. 2003;106:61-6. Review.

PMID:
15000587
10.

Antiretroviral drug resistance testing.

Sen S, Tripathy SP, Paranjape RS.

J Postgrad Med. 2006 Jul-Sep;52(3):187-93. Review.

11.

Resistance to antiretroviral therapy among patients in Uganda.

Weidle PJ, Kityo CM, Mugyenyi P, Downing R, Kebba A, Pieniazek D, Respess R, Hertogs K, De Vroey V, Dehertogh P, Bloor S, Larder B, Lackritz E.

J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):495-500.

PMID:
11391172
12.

Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells.

Sarmati L, Nicastri E, Parisi SG, d'Ettorre G, Mancino G, Narciso P, Vullo V, Andreoni M.

J Clin Microbiol. 2002 Feb;40(2):335-40.

13.

Antiretroviral resistance testing for clinical management.

Youree BE, D'Aquila RT.

AIDS Rev. 2002 Jan-Mar;4(1):3-12. Review.

PMID:
11998782
14.

Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testing.

Kartsonis NA, D'Aquila RT.

Infect Dis Clin North Am. 2000 Dec;14(4):879-99. Review.

PMID:
11144643
15.

HIV-1 drug resistance assays in clinical management.

Martinez-Picado J, D'Aquila R.

AIDS Clin Care. 1998 Nov;10(11):81-5, 87-8.

PMID:
11365861
16.

HIV-1 genotypic and phenotypic resistance.

Hanna GJ.

Clin Lab Med. 2002 Sep;22(3):637-49. Review.

PMID:
12244590
17.

A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.

Garcia-Perez J, Sanchez-Palomino S, Perez-Olmeda M, Fernandez B, Alcami J.

J Med Virol. 2007 Feb;79(2):127-37.

PMID:
17177310
18.

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Brindeiro PA, Brindeiro RM, Mortensen C, Hertogs K, De Vroey V, Rubini NP, Sion FS, De Sá CA, Machado DM, Succi RC, Tanuri A.

J Clin Microbiol. 2002 Dec;40(12):4512-9.

19.

Resistance testing.

Munk B.

Posit Aware. 1997 Jul-Aug;8(4):35-7.

PMID:
11364486
20.

Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.

Muñoz M, Carmona R, Pérez-Alvarez L, Cilla G, Suarez MD, Delgado E, Contreras G, Corral J, de Goicoetxea MJ, Medrano L, Lezaún MJ, Nájera R; Spanish Group for Antiretroviral Resistance Studies in Basque Country.

J Clin Virol. 2005 Jul;33(3):224-9. Epub 2005 Jan 12.

PMID:
15911444
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk